OTCMKTS:RDSMY - Koninklijke DSM Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 8
  • Breakdown:
  • 2 Sell Ratings
  • 2 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$41.78
▼ -0.16 (-0.38%)
1 month | 3 months | 12 months
Get New Koninklijke DSM Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RDSMY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RDSMY

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for Koninklijke DSM in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $41.78.
Hold
The current consensus among 8 contributing investment analysts is to hold stock in Koninklijke DSM.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/3/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/1/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/30/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 1 sell ratings
1/28/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 1 sell ratings
4/27/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 2 sell ratings
7/26/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 2 sell ratings
9/24/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 2 sell ratings
10/24/2020

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 2 sell ratings

DateBrokerageActionRatingPrice TargetDetails
10/14/2020Morgan StanleyReiterated RatingEqual Weight
i
10/1/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
i
7/24/2020Main First BankUpgradeHold ➝ Buy
i
7/15/2020Credit Suisse GroupReiterated RatingNeutral
i
7/8/2020UBS GroupReiterated RatingBuy
i
7/6/2020Credit Suisse GroupReiterated RatingNeutral
i
6/29/2020JPMorgan Chase & Co.Reiterated RatingOverweight
i
5/13/2020JPMorgan Chase & Co.Reiterated RatingOverweight
i
4/29/2020ING GroupDowngradeHold ➝ Sell
i
4/15/2020JPMorgan Chase & Co.Reiterated RatingOverweight
i
3/30/2020Morgan StanleyReiterated RatingEqual Weight
i
3/24/2020JPMorgan Chase & Co.Reiterated RatingOverweight
i
11/27/2019Sanford C. BernsteinDowngradeMarket Perform ➝ Underperform
i
8/5/2019ABN AmroDowngradeBuy ➝ Hold
i
7/5/2019JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight
i
2/1/2019Goldman Sachs GroupUpgradeNeutral ➝ Buy
i
11/29/2018MacquarieInitiated CoverageOutperform ➝ Outperform
i
12/1/2017Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy
i
3/28/2017Liberum CapitalUpgradeHold ➝ Buy
i
3/9/2017JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral
i
1/6/2017BarclaysUpgradeEqual Weight ➝ Overweight
i
10/26/2016JPMorgan Chase & Co.DowngradeOverweight ➝ Underweight
i
11/9/2015Liberum CapitalDowngradeBuy ➝ Hold
i
(Data available from 10/24/2015 forward)
Koninklijke DSM logo
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, rest of Europe, North America, Latin America, China, India, Japan, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, enzymes, eubiotics, carotenoids, lipids, and minerals; human nutrition and health products comprising carotenoids, digestive enzymes, nutritional lipids, nutraceuticals, probiotic and prebiotics, and vitamins; and skin and sun care, hair care, and aroma ingredients. It also provides vitamin and lipid active pharmaceutical ingredients; omega-3 fatty acids; specialty enzymes, cultures, probiotics, bio-preservation, sugar reduction, and savory taste solutions; and specialty hydrocolloid solutions. The Materials segment provides thermoplastics used in automotive, electrical and electronics, building and construction, medical, food packaging, and consumer goods; coating resins and functional materials; Dyneema, a fiber solution for use in aviation, personal protection, marine, fishing, heavy lifting, and sports and lifestyle industries; and additives. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, plastic and reconstructive surgery, soft tissue, and wound management. It also provides anti-reflective (AR) coatings for solar glass, retrofit AR and anti-soiling coatings, and conductive and PV backsheets; and yeast and enzymes for the conversion of starch, corn fiber, and biomass. The company has a partnership with Strait Access Technologies to develop trans-catheter replacement heart valves with polymeric leaflets. Koninklijke DSM N.V. was founded in 1902 and is headquartered in Heerlen, the Netherlands.
Read More

Today's Range

Now: $41.78
$41.61
$42.00

50 Day Range

MA: $41.18
$39.12
$43.33

52 Week Range

Now: $41.78
$22.86
$43.50

Volume

10,758 shs

Average Volume

12,809 shs

Market Capitalization

$30.32 billion

P/E Ratio

42.63

Dividend Yield

0.90%

Beta

0.96